| Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma O Keunen, M Johansson, A Oudin, M Sanzey, SAA Rahim, F Fack, ... Proceedings of the National Academy of Sciences 108 (9), 3749-3754, 2011 | 717 | 2011 |
| Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma S Tardito, A Oudin, SU Ahmed, F Fack, O Keunen, L Zheng, H Miletic, ... Nature cell biology 17 (12), 1556-1568, 2015 | 476 | 2015 |
| EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis KM Talasila, A Soentgerath, P Euskirchen, GV Rosland, J Wang, ... Acta neuropathologica 125, 683-698, 2013 | 155 | 2013 |
| Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas F Fack, H Espedal, O Keunen, A Golebiewska, N Obad, PN Harter, ... Acta neuropathologica 129, 115-131, 2015 | 140 | 2015 |
| Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 130 | 2022 |
| Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways F Fack, S Tardito, G Hochart, A Oudin, L Zheng, S Fritah, A Golebiewska, ... EMBO molecular medicine 9 (12), 1681-1695, 2017 | 130 | 2017 |
| EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation E Eskilsson, GV Rosland, KM Talasila, S Knappskog, O Keunen, ... Neuro-oncology 18 (12), 1644-1655, 2016 | 103 | 2016 |
| Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma S Bougnaud, A Golebiewska, A Oudin, O Keunen, PN Harter, L Mäder, ... Oncotarget 7 (22), 31955, 2016 | 92 | 2016 |
| Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology A Golebiewska, AC Hau, A Oudin, D Stieber, YA Yabo, V Baus, ... Acta Neuropathologica 140, 919-949, 2020 | 88 | 2020 |
| The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status M Johansson, A Oudin, K Tiemann, A Bernard, A Golebiewska, O Keunen, ... Neuro-oncology 15 (9), 1200-1211, 2013 | 77 | 2013 |
| Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies O Keunen, T Taxt, R Grüner, M Lund-Johansen, JC Tonn, T Pavlin, ... Advanced drug delivery reviews 76, 98-115, 2014 | 66 | 2014 |
| EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors N Dudvarski Stanković, F Bicker, S Keller, DTW Jones, PN Harter, ... EMBO molecular medicine 10 (9), e8420, 2018 | 41 | 2018 |
| Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment? A Pakzad, N Obad, H Espedal, D Stieber, O Keunen, PØ Sakariassen, ... Neuro-oncology 16 (5), 754-756, 2014 | 27 | 2014 |
| Cardiometabolic risk: leg fat is protective during childhood DF Samouda H, De Beaufort C, Stranges S, Hirsch M, Van Nieuwenhuyse JP ... Pediatric Diabetes 17 (4), 300-8, 2016 | 24 | 2016 |
| Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma N Obad, H Espedal, R Jirik, PO Sakariassen, C Brekke Rygh, ... Journal of Cerebral Blood Flow & Metabolism 38 (10), 1741-1753, 2018 | 21 | 2018 |
| Improved drug delivery to brain metastases by peptide-mediated permeabilization of the blood–brain barrier SN Aasen, H Espedal, CF Holte, O Keunen, TV Karlsen, O Tenstad, ... Molecular cancer therapeutics 18 (11), 2171-2181, 2019 | 19 | 2019 |
| Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors A Oudin, V Baus, V Barthelemy, C Fabian, E Klein, M Dieterle, M Wantz, ... STAR protocols 2 (2), 100534, 2021 | 18 | 2021 |
| Perfusion analysis of dynamic contrast enhanced magnetic resonance images using a fully continuous tissue homogeneity model with mean transit time dispersion and frequency … M Bartos, O Keunen, R Jirik, R Bjerkvig, T Taxt Anal Biomed Sign Images 20, 269-274, 2010 | 13 | 2010 |
| Epigenetic activity of peroxisome proliferator-activated receptor gamma agonists increases the anticancer effect of histone deacetylase inhibitors on multiple myeloma cells N Aouali, A Broukou, M Bosseler, O Keunen, V Schlesser, B Janji, ... PLoS One 10 (6), e0130339, 2015 | 12 | 2015 |
| Subtraction of subcutaneous fat to improve the prediction of visceral adiposity: exploring a new anthropometric track in overweight and obese youth DF Samouda H, De Beaufort C, Stranges S, Van Nieuwenhuyse JP, Dooms G ... Pediatric Diabetes, 2016 | 8* | 2016 |
Saverio TarditoCancer Research UK Beatson Institute, GlasgowVerified email at beatson.gla.ac.uk
